Hemopexin: Anti-inflammatory, pro-inflammatory, or both?

Journal of Leukocyte Biology

Volumn 87, Issue 1, 2010, Pages 1-2

  Bakker, W W ^a   Melgert, B N ^a   Faas, M M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Acute phase reactants; Inflammation; Protease

Indexed keywords

HEMOPEXIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; DOWN REGULATION; HUMAN; LETTER; MINIMAL CHANGE GLOMERULONEPHRITIS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE MARROW CELLS; FEMALE; HEMOPEXIN; HUMANS; INFLAMMATION; MACROPHAGES, PERITONEAL; MICE; NEPHROSIS, LIPOID; PREGNANCY; RENIN-ANGIOTENSIN SYSTEM; VASOCONSTRICTION;

EID: 74949099808     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0809560     Document Type: Letter

References (16)

1. Liang, X., Lin, T., Sun, G., Beasley-Topliffe, L., Cavaillon, J. M., Warren, H. S. (2009) Hemopexin down regulates LPS induced pro-inflammatory cytokines from macrophages. J. Leukoc. Biol. 86, 229-235.
2. Fink, M. P. (2009) Editorial: Hemopexin: newest member of the anti-inflammatory mediator club. J. Leukoc. Biol. 86, 203-204.
3. Johnson, A. M., Rohlfs, E. M., Silverman, L. M. (1999) Tietz Textbook of Clinical Chemistry, Philadelphia, PA, USA, W B Saunders, 444-540.
4. Tolosano, E., Altruda, F. (2002) Hemopexin: structure, function, and regulation. DNA Cell Biol. 21, 297-306.
5. Kapojos, J. J., Poelstra, K., Borghuis, T., Banas, B., Bakker, W. W. (2004) Regulation of plasma hemopexin activity by stimulated endothelial or mesangial cells. Nephron Physiol. 96, P1-P10.
6. Bakker, W. W., Borghuis, T., Harmsen, M. C., van den Berg, A., Kema, I. P., Niezen, E., Kapojos, J. J. (2005) Protease activity of plasma hemopexin. Kidney Int. 68, 603-610.
7. Cheung, P. K., Baller, J. F. W., van der Horst, M. L. C., Bakker, W. W. (1996) Impairment of endothelial and subendothelial sites by a circulating plasma factor associated with minimal change disease. Nephrol. Dial. Transplant. 11, 2185-2191.
8. Cheung, P. K., Stulp, B., Immenshuh, S., Borghuis, T., Baller, J. F., Bakker, W. W. (1999) Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF. J. Am. Soc. Nephrol. 10, 1700-1708.
9. Cheung, P. K., Klok, P. A., Baller, J. F. W., Bakker, W. W. (2000) Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int. 57, 1512-1520.
10. Lennon, R., Singh, A., Welsh, G. I., Coward, R. J., Satchell, S., Ni, L., Mathieson, P. W., Bakker, W. W., Saleem, M. A. (2008) Hemopexin induces nephrin dependent reorganization of the actin cytoskeleton in podocytes. J. Am. Soc. Nephrol. 19, 2140-2149.
11. Blau, E. B., Haas, J. E. (1973) Glomerular sialic acid and proteinuria in human renal disease. Lab. Invest. 28, 477-481.
12. Bakker, W. W., Cheung, P. K., Borghuis, T., Leemhuis, H., Poelstra, K. (2000) Ecto-ATPases and Related Ectonucleotidases, Maastricht, The Netherlands, Shaker Publishing BV, 184-191.
13. Bakker, W. W., van Dael, C. M. L., Pierik, L. J. W. M., van Wijk, J. A. E., Nauta, J., Borghuis, T., Kapojos, J. J. (2005) Altered activity of plasma hemopexin in patients with minimal change disease in relapse. Pediatr. Nephrol. 20, 1410-1415.
14. Bakker, W. W., Donker, R. B., Timmer, A., van Pampus, M. G., van Son, W. J., Aarnoudse, J. G., van Goor, H., Niezen-Koning, K. E., Navis, G. J., Borghuis, T., Jongman, R., Faas, M. M. (2007) Plasma hemopexin activity in pregnancy and preeclampsia. Hypertens. Pregnancy 26, 1-13.
15. Bakker, W. W., Henning, R. H., van Son, W. J., van Pampus, M. G., Aarnoudse, J. G., Niezen-koning, K. E., Borghuis, T., Jongman, R. M., Van Goor, H., Poelstra, K., Navis, G. J., Faas, M. M. (2009) Vascular contraction and preeclampsia; downregulation of the angiotensin receptor 1 by hemopexin in vitro. Hypertension 53, 959-964.
16. Remuzzi, G., Bertani, T. (1998) Pathophysiology of progressive nephropaties. N. Engl. J. Med. 339, 1448-1456.